CORC

在结果中检索

CORC

浏览/检索结果: 共233条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Simulation Study on Scaler Mode in LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Huang, Zhicheng;  Huang, Daihui;  Zhou, Xunxiu;  Zhao, Jing;  He, Huihai
收藏  |  浏览/下载：17/0  |  提交时间：2023/01/16
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：17/0  |  提交时间：2023/01/23
Status of the follow-up X-ray telescope onboard the Einstein probe satellite 会议论文
Virtual, Online, CA, United states, 2020-12-14
作者:  Chen, Yong;  Cui, WeiWei;  Han, DaWei;  Wang, Juan;  Yang, YangJi
收藏  |  浏览/下载：31/0  |  提交时间：2021/02/05
Seeded Free-Electron Lasers Driven by a Transverse Tilted Electron Bunch 会议论文
Australia, 2019
作者:  
收藏  |  浏览/下载：12/0  |  提交时间：2019/08/06
Complex ATP7B mutation patterns in Wilson disease and a evaluation of a yeast model for functional analysis of the individual variant 会议论文
作者:  Chen, Yongpeng;  Li, Xiaojin;  Zhang, Wei;  Zhou, Donghu;  Lv, Tingxia
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
Quantitative detection of trace H2S based on ultraviolet differential optical absorption spectroscopy (Open Access) 会议论文
作者:  Li, H.T.;  Zhao, K.;  Ma, Y.;  Jia, Y.Y.;  Liu, Y.F.
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace